|
1
|
Shenouda SK and Alahari SK: MicroRNA
function in cancer: Oncogene or a tumor suppressor? Cancer
Metastasis Rev. 28:369–378. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jovanovic M and Hengartner MO: miRNAs and
apoptosis: RNAs to die for. Oncogene. 25:6176–6187. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kent OA and Mendell JT: A small piece in
the cancer puzzle: microRNAs as tumor suppressors and oncogenes.
Oncogene. 25:6188–6196. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:pp. 2257–2261.
2006; View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang G and Yin B: The advance of
application for microRNAs in cancer gene therapy. Biomed
Pharmacother. 68:137–142. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhou X, Xia Y, Li L and Zhang G: MiR-101
inhibits cell growth and tumorigenesis of Helicobacter pylori
related gastric cancer by repression of SOCS2. Cancer Biol Ther.
16:160–169. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang XF, Li KK, Gao L, Li SZ, Chen K,
Zhang JB, Wang D, Tu RF, Zhang JX, Tao KX, et al: miR-191 promotes
tumorigenesis of human colorectal cancer through targeting C/EBPβ.
Oncotarget. 6:4144–4158. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shen S, Guo X, Yan H, Lu Y, Ji X, Li L,
Liang T, Zhou D, Feng XH, Zhao JC, et al: A miR-130a-YAP positive
feedback loop promotes organ size and tumorigenesis. Cell Res.
25:997–1012. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ding L, Ai D, Wu R, Zang T, Jing L, Lu J
and Zhong L: Identification of the differential expression of serum
microRNA in type 2 diabetes. Biosci Biotechnol Biochem. 80:461–465.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Watanabe K, Hasegawa Y, Yamashita H,
Shimizu K, Ding Y, Abe M, Ohta H, Imagawa K, Hojo K, Maki H, et al:
Vasohibin as an endothelium-derived negative feedback regulator of
angiogenesis. J Clin Invest. 114:898–907. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kimura H, Miyashita H, Suzuki Y, Kobayashi
M, Watanabe K, Sonoda H, Ohta H, Fujiwara T, Shimosegawa T and Sato
Y: Distinctive localization and opposed roles of vasohibin-1 and
vasohibin-2 in the regulation of angiogenesis. Blood.
113:4810–4818. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using quantitative PCR and the
2-(Delta DeltaC(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Giacco F and Brownlee M: Oxidative stress
and diabetic complications. Circ Res. 107:1058–1070. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Du Y, Veenstra A, Palczewski K and Kern
TS: Photoreceptor cells are major contributors to diabetes-induced
oxidative stress and local inflammation in the retina. Proc Natl
Acad Sci USA. 110:pp. 16586–16591. 2013; View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tang J and Kern TS: Inflammation in
diabetic retinopathy. Prog Retin Eye Res. 30:343–358. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hanahan D and Folkman J: Patterns and
emerging mechanisms of the angiogenic switch during tumorigenesis.
Cell. 86:353–364. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kerbel RS: Vasohibin: The feedback on a
new inhibitor of angiogenesis. J Clin Invest. 114:884–886. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shimizu K, Watanabe K, Yamashita H, Abe M,
Yoshimatsu H, Ohta H, Sonoda H and Sato Y: Gene regulation of a
novel angiogenesis inhibitor, vasohibin, in endothelial cells.
Biochem Biophys Res Commun. 327:700–706. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li D, Zhou K, Wang S, Shi Z and Yang Z:
Recombinant adenovirus encoding vasohibin prevents tumor
angiogenesis and inhibits tumor growth. Cancer Sci. 101:448–452.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hosaka T, Kimura H, Heishi T, Suzuki Y,
Miyashita H, Ohta H, Sonoda H, Moriya T, Suzuki S, Kondo T and Sato
Y: Vasohibin-1 expression in endothelium of tumor blood vessels
regulates angiogenesis. Am J Pathol. 175:430–439. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yoshinaga K, Ito K, Moriya T, Nagase S,
Takano T, Niikura H, Yaegashi N and Sato Y: Expression of vasohibin
as a novel endothelium-derived angiogenesis inhibitor in
endometrial cancer. Cancer Sci. 99:914–919. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tamaki K, Moriya T and Sato Y, Nagase S,
Takano T, Niikura H, Yaegashi N and Sato Y: Vasohibin-1 in human
breast carcinoma: A potential negative feedback regulator of
angiogenesis. Cancer Sci. 100:88–94. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sato H, Abe T, Wakusawa R, Asai N,
Kunikata H, Ohta H, Sonoda H, Sato Y and Nishida K: Vitreous levels
of vasohibin-1 and vascular endothelial growth factor in patients
with proliferative diabetic retinopathy. Diabetologia. 52:359–361.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shen J, Yang X, Xiao WH, Hackett SF, Sato
Y and Campochiaro PA: Vasohibin is up-regulated by VEGF in the
retina and suppresses VEGF receptor 2 and retinal
neovascularization. FASEB J. 20:723–725. 2006.PubMed/NCBI
|
|
25
|
Yamashita H, Abe M, Watanabe K, Shimizu K,
Moriya T, Sato A, Satomi S, Ohta H, Sonoda H and Sato Y: Vasohibin
prevents arterial neointimal formation through angiogenesis
inhibition. Biochem Biophys Res Commun. 345:919–925. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Heishi T, Hosaka T, Suzuki Y, Miyashita H,
Oike Y, Takahashi T, Nakamura T, Arioka S, Mitsuda Y, Takakura T,
et al: Endogenous angiogenesis inhibitor vasohibin1 exhibits
broad-spectrum antilymphangiogenic activity and suppresses lymph
node metastasis. Am J Pathol. 176:1950–1958. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Miyashita H, Watanabe T, Hayashi H, Suzuki
Y, Nakamura T, Ito S, Ono M, Hoshikawa Y, Okada Y, Kondo T and Sato
Y: Angiogenesis inhibitor vasohibin-1 enhances stress resistance of
endothelial cells via induction of SOD2 and SIRT1. PLoS One.
7:e464592012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sato Y: Is vasohibin-1 for more than
angiogenesis inhibition? J Biochem. 149:229–230. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yan Y, Shen Z, Ye Y, Jiang K, Zhang H,
Shen C, Mustonen H, Puolakkainen P and Wang S: A novel molecular
marker of prognosis in colorectal cancer: Vasohibin-1. Med Oncol.
31:8162014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu S, Han B, Zhang Q, Dou J, Wang F, Lin
W, Sun Y and Peng G: Vasohibin-1 suppresses colon cancer.
Oncotarget. 6:7880–7898. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tamaki K, Sasano H, Maruo Y, Takahashi Y,
Miyashita M, Moriya T, Sato Y, Hirakawa H, Tamaki N, Watanabe M, et
al: Vasohibin-1 as a potential predictor of aggressive behavior of
ductal carcinoma in situ of the breast. Cancer Sci. 101:1051–1058.
2010. View Article : Google Scholar : PubMed/NCBI
|
